SCHEMBL4115873

SCHEMBL4115873

O=Cc1cccc(OC(F)F)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 3/20 0.45
ALDH1A1 P00352 4/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ERN1 O75460 2/20 0.40
TLR2 O60603 1/20 0.40
TLR1 Q15399 1/20 0.40
TLR6 Q9Y2C9 1/20 0.40
POLB P06746 1/20 0.38
LMNA P02545 3/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
BLM P54132 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
SRC P12931 2/20 0.36
PTGES2 Q9H7Z7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16962325 0.82 ALDH1A1 (0.39) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL16962329 0.82 ALDH1A1 (0.42) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL5083611 0.81 DRD1 (0.47) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL29538287 0.81 ALDH1A1 (0.55) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL908602 0.81 ALDH1A1 (0.55) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL27034832 0.80 DRD1 (0.50) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL30768062 0.80 DRD1 (0.50) DRD1ALDH1A1HPGDHTTSMN1; SMN2
SCHEMBL1299789 0.76 RORC (0.43) ALDH1A1HPGDHTTSMN1; SMN2ERN1
SCHEMBL63899 0.76 ERN1 (0.61) ALDH1A1HPGDHTTSMN1; SMN2ERN1
SCHEMBL320171 0.75 ALDH1A1 (0.55) DRD1ALDH1A1HTTSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR DRD1 2352/4885ALDH1A1 1587/4885HPGD 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.